Clinical Trial Update: Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing tipifarnib to best supportive care in newly diagnosed acute myeloid leukemia has completed; the brief update does not provide trial ou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Tipifarnib (tipifarnib)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED